BamSEC and AlphaSense Join Forces
Learn More

NovaBay Pharmaceuticals Inc.

NYSE American: NBY    
Share price (9/12/25): $2.59    
Market cap (9/12/25): $15.1 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 9 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.] Trademark Acquisition Agreement
12/34/56
EX-2.1
from 8-K 87 pages Amendment No. 1 to Asset Purchase Agreement
12/34/56
EX-2.1
from DEFA14A 87 pages Amendment No. 1 to Asset Purchase Agreement
12/34/56
EX-2.2
from DEFA14A 3 pages Plan of Complete Liquidation and Dissolution of NovaBay Pharmaceuticals, Inc
12/34/56
EX-2.2
from 8-K 3 pages Plan of Complete Liquidation and Dissolution of NovaBay Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 83 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.]
12/34/56
EX-2.1
from DEFA14A 83 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.]
12/34/56
EX-2.1
from 8-K 45 pages Membership Unit Purchase Agreement
12/34/56
EX-2.1
from 8-K 96 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.]
12/34/56
EX-2.1
from POS AM 5 pages Agreement and Plan of Merger of Novabay Pharmaceuticals, Inc. (A California Corporation) and Novabay Pharmaceuticals, Inc
12/34/56